Cargando…
A twelve-gene signature for survival prediction in malignant melanoma patients
BACKGROUND: Melanoma is defined as a highly mutational heterogeneous disease containing numerous alternations of the molecule. However, due to the phenotypically and genetically heterogeneity of malignant melanoma, conventional clinical characteristics remain restricted or limited in the ability to...
Autores principales: | Song, Le-Bin, Zhang, Qi-Jie, Hou, Xiao-Yuan, Xiu, Yan-Yan, Chen, Lin, Song, Ning-Hong, Lu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186619/ https://www.ncbi.nlm.nih.gov/pubmed/32355756 http://dx.doi.org/10.21037/atm.2020.02.132 |
Ejemplares similares
-
The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma
por: Song, Le-Bin, et al.
Publicado: (2021) -
A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
por: Wu, Jin, et al.
Publicado: (2022) -
A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020) -
A new metabolic signature contributes to disease progression and predicts worse survival in melanoma
por: Wan, Mengdi, et al.
Publicado: (2020) -
Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma
por: Zhu, Sihan, et al.
Publicado: (2020)